LIGHT-UP: GS200 may improve insulin sensitivity and positively impact metabolic syndrome
Outcomes from the LIGHT-UP study that evaluated the safety and efficacy of GS200, an investigational oral hydrogel, has concluded the...
Browse by category
Search
Gelesis announces merger with Capstar Special
Gelesis, a biotherapeutics company advancing biomimetic superabsorbent hydrogels to treat excess weight and metabolic disorders, and...
Plenity induced weight loss results in NALFD fibrosis score improvement
A post-hoc analysis showed that treatment for weight management with Plenity decreased a marker for liver fibrosis (the NAFLD fibrosis...
Gelesis gains European approval for PLENITY weight loss treatment
Gelesis, a biotechnology company developing a novel hydrogel platform technology to treat obesity and other chronic diseases related to...
